Clinical Trials Logo

Genital Wart clinical trials

View clinical trials related to Genital Wart.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06465914 Not yet recruiting - Anal Cancer Clinical Trials

A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males

Start date: July 30, 2024
Phase: Phase 3
Study type: Interventional

This study is designed to evaluate the vaccine efficacy, immunogenicity and safety of the 9-valent (Types 6, 11, 16, 18, 31, 33, 45, 52 and 58) Human Papillomavirus (HPV) Recombinant Vaccine (Hansenula Polymorpha) in Chinese male subjects aged 18-45 years. The primary hypothesis in the study is the 9-valent HPV recombinant vaccine reduces the incidence of vaccine HPV types-related genital warts compared with placebo in Chinese men.

NCT ID: NCT06454175 Not yet recruiting - HPV Infection Clinical Trials

A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years

Start date: July 5, 2024
Phase: Phase 1
Study type: Interventional

To evaluate the safety and tolerability of 15-valent HPV vaccine in 9-45year-old participants.

NCT ID: NCT03153566 Not yet recruiting - Genital Wart Clinical Trials

Comparison Between Tuberculin Vaccine and Cryotherapy in Genital Wart Patients

Start date: June 1, 2017
Phase: Phase 3
Study type: Interventional

Cutaneous and genital warts are common dermatological conditions caused by Human Papilloma Virus. Although it is a benign condition it causes disfigurement, has tendency to collect, can be transmitted to others, this makes adequate and timely treatment important, while many warts are resolve spontaneously over several years, most patients seek treatment because the warts are unsightly and often tender or painful.